Page 11234..1020..»

Category Archives: Oncology

Tyler mom beats cancer, punches bell in epic fashion exiting oncology center – KVUE

Posted: June 25, 2017 at 3:43 am

Wendy Freden literally punched the cancer bell on her way out of the oncology office. Kris Kirst, KYTX 1:00 PM. Continue reading



Source Link(s) Are Here

Tyler mom beats cancer, punches bell in epic fashion exiting oncology center - KVUE

Posted in Oncology | Comments Off on Tyler mom beats cancer, punches bell in epic fashion exiting oncology center – KVUE

What To Expect From Clovis Oncology Following Rubraca Approval – Benzinga

Posted: June 23, 2017 at 8:44 pm

Clovis Oncology Inc (NASDAQ: CLVS) investors certainly have reason to be excited about the potential of the companys Rubraca cancer treatment drug. However, Oppenheimer analyst Leah Cann isnt quite so excited about Clovis stock at its current price. On Thursday, Oppenheimer initiated coverage of Clovis with a Perform rating. Continue reading



Source Link(s) Are Here

What To Expect From Clovis Oncology Following Rubraca Approval - Benzinga

Posted in Oncology | Comments Off on What To Expect From Clovis Oncology Following Rubraca Approval – Benzinga

New Oncology Launch Study Probes the Investment and Staffing Levels Needed to Successfully Launch a Cancer … – PR Newswire (press release)

Posted: at 8:44 pm

Research and consulting leader Best Practices, LLC undertook a primary research project to provide oncology leaders with current staffing and investment benchmarks for launch-related activities and functions for new oncology products. This study will help marketing and brand leaders identify staffing and investment priorities across pre-launch, launch and post-launch activities for oncology products. Continue reading



Source Link(s) Are Here

New Oncology Launch Study Probes the Investment and Staffing Levels Needed to Successfully Launch a Cancer ... - PR Newswire (press release)

Posted in Oncology | Comments Off on New Oncology Launch Study Probes the Investment and Staffing Levels Needed to Successfully Launch a Cancer … – PR Newswire (press release)

AVEO Oncology (AVEO) Announces Positive CHMP Opinion for Tivozanib as Treatment of Advanced Renal Cell … – StreetInsider.com

Posted: at 8:44 pm

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com’s Dividend Insider Elite. Sign-up for a FREE trial here. AVEO Oncology (NASDAQ: AVEO) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has recommended FOTIVDA (tivozanib) for approval as a treatment for patients with advanced renal cell carcinoma (RCC). Continue reading



Source Link(s) Are Here

AVEO Oncology (AVEO) Announces Positive CHMP Opinion for Tivozanib as Treatment of Advanced Renal Cell ... - StreetInsider.com

Posted in Oncology | Comments Off on AVEO Oncology (AVEO) Announces Positive CHMP Opinion for Tivozanib as Treatment of Advanced Renal Cell … – StreetInsider.com

The US Oncology Network Hosts Second Annual Boot Camp … – Business Wire (press release)

Posted: at 8:44 pm

THE WOODLANDS, Texas–(BUSINESS WIRE)–The US Oncology Network (The Network) hosted its second annual boot camp last month in Dallas, focusing on various value-based care delivery and reimbursement models. The intensive two-day workshop brought together more than 100 key stakeholders and thought leaders in value-based care, including physicians, clinical staff, quality leads, and executive leaders from The US Oncology Network affiliated practices across the nation Continue reading



Source Link(s) Are Here

The US Oncology Network Hosts Second Annual Boot Camp ... - Business Wire (press release)

Posted in Oncology | Comments Off on The US Oncology Network Hosts Second Annual Boot Camp … – Business Wire (press release)

How Dow’s Merck Is Still Beating Bristol, Roche In Immuno-Oncology – Investor’s Business Daily

Posted: June 22, 2017 at 10:44 am

Merck’s (MRK) Keytruda continued to gain share over immuno-oncology drugs from Bristol-Myers Squibb (BMY) and Roche (RHHBY) in May after the approval of its Keytruda-plus-chemotherapy combination. Overall immuno-oncology drug sales grew 18% month over month in May to $602 million, data from Symphony Health show. Merck’s Keytruda is gaining share at the expense of Bristol’s Opdivo and Yervoy, Leerink analyst Seamus Fernandez says. Continue reading



Source Link(s) Are Here

How Dow's Merck Is Still Beating Bristol, Roche In Immuno-Oncology - Investor's Business Daily

Posted in Oncology | Comments Off on How Dow’s Merck Is Still Beating Bristol, Roche In Immuno-Oncology – Investor’s Business Daily

Transgene Hosts Immuno-Oncology R&D Day Focused on Modulating the Tumor Micro-Environment in Paris – Business Wire (press release)

Posted: at 10:44 am

STRASBOURG, France–(BUSINESS WIRE)–Regulatory News: Transgene (Euronext Paris:TNG), a biotech company that designs and develops viral-based immunotherapies, will host today an Immuno-Oncology R&D event for investors and analysts in Paris. The event, which features presentations by leading clinicians and scientists from around the world as well as key members of the Transgene management team, provides an update on: Philippe Archinard, PhD, Chairman and CEO, Transgene, commenting on the Companys R&D day said : Todays event demonstrates that Transgene is rapidly positioning itself to become a key player in the field of immuno-oncology Continue reading



Source Link(s) Are Here

Transgene Hosts Immuno-Oncology R&D Day Focused on Modulating the Tumor Micro-Environment in Paris - Business Wire (press release)

Posted in Oncology | Comments Off on Transgene Hosts Immuno-Oncology R&D Day Focused on Modulating the Tumor Micro-Environment in Paris – Business Wire (press release)

Grand Valley Oncology Offers Clinical Trials – Story – WesternSlopeNow

Posted: at 10:44 am

GRAND JUNCTION, Colo.- – Grand Valley Oncology and the Huntsman Cancer Institute at the University of Utah are now offering clinical trials for cancer patients. This is the first center in the intermountain West region to establish clinical trials. Officials say clinical trials have many benefits for cancer patients Continue reading



Source Link(s) Are Here

Grand Valley Oncology Offers Clinical Trials - Story - WesternSlopeNow

Posted in Oncology | Comments Off on Grand Valley Oncology Offers Clinical Trials – Story – WesternSlopeNow

Clovis Oncology, Inc. (CLVS) Worth a Look: Stock Jumps 6.3% – Zacks.com

Posted: at 10:44 am

Clovis Oncology, Inc. (CLVS – Free Report) was a big mover last session, as the company saw its shares rise over 6% on the day Continue reading



Source Link(s) Are Here

Clovis Oncology, Inc. (CLVS) Worth a Look: Stock Jumps 6.3% - Zacks.com

Posted in Oncology | Comments Off on Clovis Oncology, Inc. (CLVS) Worth a Look: Stock Jumps 6.3% – Zacks.com

Merck Ventures, CRUK launch new immuno-oncology spinout biotech iOnctura – FierceBiotech

Posted: June 21, 2017 at 12:43 pm

German Merck, fresh off it and partner Pfizers FDA approval for their checkpoint inhibitor Bavencio, and R&D charity CRUK are coming together to launch a biotech focused on immuno-oncology. The company, callediOnctura, has come to life via its venture arm Merck Ventures and is formed around two assets from the pipeline of Merck and three assets from Cancer Research Technology (CRT), the commercial arm of Londons Cancer Research U.K. (CRUK) Continue reading



Source Link(s) Are Here

Merck Ventures, CRUK launch new immuno-oncology spinout biotech iOnctura - FierceBiotech

Posted in Oncology | Comments Off on Merck Ventures, CRUK launch new immuno-oncology spinout biotech iOnctura – FierceBiotech

Page 11234..1020..»